Investment
Features
FeesSafety
Academy
More
Pluang+

Compare uniQure N.V. Ordinary Shares (QURE) vs Teck Resources (TECK) Price & Performance

uniQure N.V. Ordinary SharesTrade
Teck ResourcesTrade

Price performance (Past 24H)

Key statistics

uniQure N.V. Ordinary Shares vs Teck Resources — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while Teck Resources trades at $64.35 (market cap $32.79B). The key difference: Teck Resources is far larger — about 22.2× uniQure N.V. Ordinary Shares's market cap, and Teck Resources pays a 0.53% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Teck Resources for 15 Days on average.

QURETECK
Market Cap
$1.48B$32.79B
Volume
2,488,7801,600,168
Sector
HealthBasic Materials
52-Week High
$70.59$71.97
52-Week Low
$9.03$38.23
Typical Hold Time
0 Days15 Days
Enterprise Value
$728.62M$35.41B
Dividend Yield
—0.53%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Teck Resources

TECK trades at $67.17, down 0.55% today, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. Revenue and net income are projected to grow significantly in 2026, supported by a 17.85% net margin. Analyst consensus is strongly bullish, with 69% buy ratings, amid positive news flow including inclusion in Forbes' top companies for women and copper price optimism.

Outlook remains positive given earnings momentum and copper demand tailwinds, but risks include commodity price volatility and execution of the Anglo American merger. Cash flow turned positive in 2026 forecasts, though 2025 saw a net outflow. The stock offers value with a P/E of 18.82 and EV/EBITDA of 7.77, but investors should monitor merger progress and global economic conditions.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QURE
100% Buy0% Sell
Avg holding period · 0 Days
TECK

No sentiment data available yet.

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →

About Teck Resources

Teck Resources is a mining company focused on producing metals and minerals, including copper and zinc. Its operations supply materials used in infrastructure, manufacturing, and energy-related industries.

Read more on TECK →